A detailed history of Strategic Blueprint, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Strategic Blueprint, LLC holds 3,051 shares of ZTS stock, worth $531,606. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,051
Previous 2,836 7.58%
Holding current value
$531,606
Previous $559,000 7.69%
% of portfolio
0.04%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$165.67 - $199.94 $35,619 - $42,987
215 Added 7.58%
3,051 $516,000
Q4 2023

Jan 25, 2024

SELL
$151.44 - $200.09 $18,021 - $23,810
-119 Reduced 4.03%
2,836 $559,000
Q3 2023

Oct 18, 2023

SELL
$167.14 - $192.77 $5,348 - $6,168
-32 Reduced 1.07%
2,955 $514,000
Q2 2023

Oct 18, 2023

SELL
$160.94 - $186.23 $87,229 - $100,936
-542 Reduced 15.36%
2,987 $514,000
Q1 2023

Apr 28, 2023

BUY
$145.48 - $175.02 $37,242 - $44,805
256 Added 7.82%
3,529 $587,000
Q4 2022

Jan 26, 2023

SELL
$131.14 - $157.47 $2,098 - $2,519
-16 Reduced 0.49%
3,273 $0
Q3 2022

Nov 08, 2022

BUY
$148.29 - $182.55 $106,027 - $130,523
715 Added 27.78%
3,289 $488,000
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $1,403 - $1,800
9 Added 0.35%
2,574 $442,000
Q1 2022

Aug 12, 2022

SELL
$181.39 - $234.03 $53,691 - $69,272
-296 Reduced 10.35%
2,565 $484,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $111,952 - $142,783
578 Added 25.32%
2,861 $698,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $614,624 - $680,863
-3,247 Reduced 58.72%
2,283 $443,000
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $551,106 - $664,544
3,535 Added 177.19%
5,530 $1.03 Million
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $22,896 - $26,933
159 Added 8.66%
1,995 $314,000
Q4 2020

Jan 26, 2021

SELL
$157.07 - $174.35 $563,253 - $625,219
-3,586 Reduced 66.14%
1,836 $304,000
Q3 2020

Oct 27, 2020

BUY
$137.1 - $165.37 $743,356 - $896,636
5,422 New
5,422 $897,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.